Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
36
AGIO Quote, Financials, Valuation and Earnings
Last price:
$29.19
Seasonality move
:
6.83%
Day range:
$27.10 - $30.04
52-week range:
$22.24 - $46.00
Dividend yield:
0%
P/E ratio:
3.91x
P/S ratio:
37.58x
P/B ratio:
1.33x
Volume:
915.7K
Avg. volume:
2.4M
1-year change:
-14.68%
Market cap:
$1.7B
Revenue:
$36.5M
EPS (TTM):
-$6.96
Earnings Data
Next earnings date for AGIO
Feb 12
2026
Most recent earnings per share
-$1.78
Beat by $0.13
(Oct 30/2025)
Consensus Estimate
-$1.90
(Oct 30/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
AGIO Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/12/2026 | Q4 | $11.9M | -- | -- | -$1.94 | -- |
| 10/30/2025 | Q3 | $10.6M | $12.9M | -$1.78 | -$1.90 | $0.13 |
| 07/31/2025 | Q2 | $9.5M | $12.5M | -$1.93 | -$1.75 | -$0.18 |
| 05/01/2025 | Q1 | $9.7M | $8.7M | -$1.55 | -$1.76 | $0.21 |
| 02/13/2025 | Q4 | $9.3M | $10.7M | -$1.69 | -$1.63 | -$0.06 |
| 10/31/2024 | Q3 | $9.5M | $9M | $16.22 | $7.91 | $8.31 |
| 08/01/2024 | Q2 | $9.3M | $8.6M | -$1.69 | -$1.61 | -$0.08 |
| 05/02/2024 | Q1 | $8.4M | $8.2M | -$1.45 | -$1.69 | $0.24 |
| 02/15/2024 | Q4 | $7.9M | $7.1M | -$1.72 | -$1.64 | -$0.08 |
| 11/02/2023 | Q3 | -- | -- | -$1.64 | -$1.64 | -$0.00 |
| 08/03/2023 | Q2 | -- | -- | -$1.51 | -$1.50 | -$0.01 |
| 05/04/2023 | Q1 | -- | -- | -$1.47 | -$1.72 | $0.25 |
| 02/23/2023 | Q4 | -- | -- | $0.67 | -$1.54 | $2.21 |
| 11/03/2022 | Q3 | -- | -- | -$1.49 | -$1.71 | $0.22 |
| 08/04/2022 | Q2 | -- | -- | -$1.68 | -$1.78 | $0.10 |
| 05/05/2022 | Q1 | -- | -- | -$1.74 | -$1.76 | $0.02 |
| 02/24/2022 | Q4 | -- | -- | -$1.74 | -$1.57 | -$0.17 |
| 11/03/2021 | Q3 | -- | -- | -$1.56 | -$1.57 | $0.01 |
| 07/29/2021 | Q2 | -- | -- | -$1.41 | -$1.28 | -$0.13 |
| 04/29/2021 | Q1 | -- | -- | $26.95 | -$1.26 | $28.21 |
| 02/25/2021 | Q4 | -- | -- | -$1.41 | -$1.31 | -$0.10 |
| 11/05/2020 | Q3 | -- | -- | -$1.43 | -$1.36 | -$0.07 |
| 07/30/2020 | Q2 | -- | -- | -$1.31 | -$1.36 | $0.05 |
| 04/30/2020 | Q1 | -- | -- | -$0.59 | -$1.64 | $1.05 |
| 02/13/2020 | Q4 | -- | -- | -$1.60 | -$1.68 | $0.08 |
| 10/31/2019 | Q3 | -- | -- | -$1.81 | -$1.81 | -$0.00 |
| 08/01/2019 | Q2 | -- | -- | -$1.87 | -$1.70 | -$0.17 |
| 05/02/2019 | Q1 | -- | -- | -$1.59 | -$1.75 | $0.16 |
| 02/14/2019 | Q4 | -- | -- | -$1.58 | -$1.66 | $0.08 |
| 11/01/2018 | Q3 | -- | -- | -$1.63 | -$1.62 | -$0.01 |
| 08/02/2018 | Q2 | -- | -- | -$1.19 | -$1.55 | $0.36 |
| 05/04/2018 | Q1 | -- | -- | -$1.63 | -$1.65 | $0.02 |
| 02/14/2018 | Q4 | -- | -- | -$1.81 | -$1.61 | -$0.20 |
| 11/01/2017 | Q3 | -- | -- | -$1.59 | -$1.78 | $0.19 |
| 08/08/2017 | Q2 | -- | -- | -$1.78 | -$1.57 | -$0.21 |
| 05/04/2017 | Q1 | -- | -- | -$1.56 | -$1.80 | $0.24 |
| 02/16/2017 | Q4 | -- | -- | -$1.34 | -$1.51 | $0.17 |
| 11/03/2016 | Q3 | -- | -- | -- | -- | -- |
| 08/04/2016 | Q2 | -- | -- | -- | -- | -- |
| 05/05/2016 | Q1 | -- | -- | -- | -- | -- |
| 02/18/2016 | Q4 | -- | -- | -- | -- | -- |
Agios Pharmaceuticals, Inc. Earnings Questions
-
How Much did Agios Pharmaceuticals, Inc. Generate in Revenue Last Quarter?
Agios Pharmaceuticals, Inc. reported $12.9M worth of top line sales in its most recent quarter.
-
Did Agios Pharmaceuticals, Inc. Beat Earnings Last Quarter?
Agios Pharmaceuticals, Inc. announced earnings per share of -$1.78 which represents a beat of analyst forecast a -$1.90 per share.
-
Is Agios Pharmaceuticals, Inc. Profitable?
Agios Pharmaceuticals, Inc. reported $9.8M that represents $0.17 per share over the last quarter.
-
What is the Analyst Consensus for Agios Pharmaceuticals, Inc. EPS Next Year?
Agios Pharmaceuticals, Inc.'s earnings are forecast to decrease from $11.64 per share to $11.21 per share next year representing a decrease of -69.54%.
-
When is Agios Pharmaceuticals, Inc.'s Earnings Date?
Agios Pharmaceuticals, Inc.'s next earnings date is February 12, 2026.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
